MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$1,388K
EPS
-$0.06
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
619
684
538
608
General and administrative
798
1,006
877
827
Total operating expenses
1,417
1,690
1,415
1,435
Loss from operations
-1,417
-1,690
-1,415
-1,435
Interest income
29
36
50
37
Total other income
29
36
50
37
Net loss
-1,388
-1,654
-1,365
-1,398
Basic EPS
-0.06
-0.08
-0.067
-0.07
Diluted EPS
-0.06
-0.08
-0.067
-0.07
Basic Average Shares
21,420,479
21,010,132
20,416,613
20,206,033
Diluted Average Shares
21,420,479
21,010,132
20,416,613
20,206,033
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
KAPA Income Statement Sankey Diagram
Sankey diagram visualizing KAPA income statement for the period
Interest income
$29K
(-14.71%↓ Y/Y)
Net loss
-$1,388K
(2.39%↑ Y/Y)
Total other income
$29K
(-14.71%↓ Y/Y)
Loss from operations
-$1,417K
(2.68%↑ Y/Y)
Total operating
expenses
$1,417K
(-2.68%↓ Y/Y)
General and
administrative
$798K
(-16.88%↓ Y/Y)
Research and development
$619K
(24.80%↑ Y/Y)
Buy us a coffee
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)